Screening for XXXX in Europe. Hungary.

@entity1 @entity0 @entity5 @entity378 @entity204
In Hungary, the incidence of @entity0 , the fourth leading cause of @entity204 among @entity1 , almost doubled in every age group during the period 1970-94. Hungary has instituted a mass screening project in response to this situation. Screening for @entity0 is combined with screening for @entity378 , and manual breast examination is now a routine part of every gynecological examination. @entity1 are also being trained to examine their own breasts for changes. Treatment for @entity0 consists of total or partial mastectomy with removal of the axillar lymph nodes if necessary. Radiotherapy and adjuvant chemotherapy are also available. Data on @entity5 gathered in 1988 indicate that morbidity is 26.7-28.3/100,000 and that the @entity204 rate has not changed in the past 25 years. The incidence of @entity5 has increased dramatically, however, in the population aged between 15 and 39 years and over 80 years. Gynecologists usually provide routine screening for @entity5 using oncocytology or, where available, colposcopic examination. @entity1 must be informed about the importance of screening for early detection and treatment of @entity5 .
